It’s an arms race and one we’re losing. MRSA is a bacterial infection that’s evolved to resist just about everything medicine can throw at it including methicillin, amoxicillin, penicillin and oxacillin.
People at, or having recently left, hospitals in Spain have a 6 to 8 percent chance of contracting an infection, according to a new report. The issue is a further example of the rise in antimicrobial resistant bacteria.
A strain of the MRSA superbug linked to the overuse of antibiotics has been discovered in pork sold by several prominent British supermarkets, according to an investigation by The Guardian.
Astonishingly, a remedy called "Bard's eyesalve" found in a 10th century Anglo-Saxon manuscript is creating quite a stir in modern day medical circles. The remedy can actually kill Methicillin-resistant Staphylococcus aureus (MRSA).
The number of cases of hospital acquired infection in English hospitals has slowed down, meaning fewer people are contracting pathogens like MRSA from the clinical setting. However, rates of C. diff are up.
The primary type of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infecting people in Europe, the Middle East and northern Africa, is derived from a single sub-Saharan ancestor, according to a new study.
The latest genetic sequencing technologies have been utilized to develop new methods to identify genes which are important for the survival of bacterial infections in pigs. This is seen as an important step for reducing infection in livestock.
People living near pig farms or agricultural fields fertilized with pig manure are more likely to become infected with methicillin-resistant Staphylococcus aureus (MRSA) bacteria, new research suggests.
Researchers have found that a current HIV drug called maraviroc could be a potential therapy for Staphylococcus aureus, a pathogen linked to hundreds of thousands of hospitalizations each year as well as being a common hospital ‘superbug’.